EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Merkel Cell Carcinoma

Jennifer Strong, Patrick Hallaert, Isaac Brownell

Hematology/Oncology Clinics of North America · 2024

DOI: 10.1016/j.hoc.2024.05.013 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Hematology/Oncology Clinics of North America, 2024. Verfasst von Jennifer Strong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Branch, NIAMS, NIH, 10 Center Drive, 12N240C, Bethesda, MD 20892-1908, USA. Hauptthemen laut MEDLINE: Carcinoma, Merkel Cell, Skin Neoplasms, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, National Institutes of Health, U.S. Department of Health and Human Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine skin cancer that is highly radiosensitive and immunogenic. Immunotherapy is the primary treatment of advanced disease, and immune checkpoint inhibitors show promise as neoadjuvant or adjuvant therapy in patients with high-risk resectable MCC. Emerging biomarkers of tumor burden are becoming increasingly important in identifying high-risk patients and in post-treatment surveillance. Further research is needed to determine the optimal duration of anti-PD-(L)1 treatment and second-line options for patients with MCC refractory to immunotherapy. This review covers the characteristics and management of MCC including recent innovations and areas of active investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Merkel CellSkin NeoplasmsImmune Checkpoint InhibitorsHumansImmunotherapyBiomarkers, TumorDisease Management

Stichwörter der Autor:innen

ImmunotherapyMerkel cell carcinomaMerkel cell polyomavirusNeuroendocrineSkin cancer

Substanzen

Immune Checkpoint InhibitorsBiomarkers, Tumor

Autor:innen und Institutionen

  • Dermatology Branch, NIAMS, NIH, 10 Center Drive, 12N240C, Bethesda, MD 20892-1908, USA.
  • Dermatology Branch, NIAMS, NIH, 10 Center Drive, 12N240C, Bethesda, MD 20892-1908, USA. Electronic address: isaac.brownell@nih.gov.

Förderung

  • Intramural NIH HHS
  • National Institutes of Health
  • U.S. Department of Health and Human Services
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases

Zitieren

APA

Strong, J., Hallaert, P., & Brownell, I. (2024). Merkel Cell Carcinoma. Hematology/Oncology Clinics of North America. https://doi.org/10.1016/j.hoc.2024.05.013

Vancouver

Strong J, Hallaert P, Brownell I. Merkel Cell Carcinoma. Hematology/Oncology Clinics of North America. 2024. doi:10.1016/j.hoc.2024.05.013

BibTeX
@article{Strong2024,
  author = {Strong, Jennifer and Hallaert, Patrick and Brownell, Isaac},
  title = {Merkel Cell Carcinoma},
  journal = {Hematology/Oncology Clinics of North America},
  year = {2024},
  doi = {10.1016/j.hoc.2024.05.013}
}
Kostenlos starten →